UPDATE: Mizuho Securities Downgrades Sage Therapeutics (SAGE) to Neutral
Tweet Send to a Friend
(Updated - February 26, 2021 5:21 AM EST)
Mizuho Securities analyst Vamil Divan downgraded Sage Therapeutics (NASDAQ: SAGE) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Mizuho Securities analyst Vamil Divan downgraded Sage Therapeutics (NASDAQ: SAGE) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
